Area of research
Infectious Diseases · Surgery
Research interest
Research interests include Staphylococcus aureus, Microbiology, Medicine, Biology, Antibiotics, and Methicillin-resistant Staphylococcus aureus.
Intracellular Staphylococcus aureus in osteoblasts and osteocytes and its impact on bone homeostasis during osteomyelitis
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
<i>Staphylococcus capitis</i> : insights into epidemiology, virulence, and antimicrobial resistance of a clinically relevant bacterial species
Phage susceptibility testing methods or ‘phagograms’: where do we stand and where should we go?
Rationalisation of the purification process for a phage active pharmaceutical ingredient
Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections
Emergence of methicillin resistance predates the clinical use of antibiotics
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection
Paving the way for phage therapy using novel drug delivery approaches
Microscopy-based phenotypic profiling of infection by Staphylococcus aureus clinical isolates reveals intracellular lifestyle as a prevalent feature
Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages
Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant <i>Staphylococcus epidermidis</i> clone harbouring the <i>cfr</i> linezolid resistance gene in a French hospital with evidence of interspecies transfer to several <i>Staphylococcus aureus</i> lineages
Prophylactic Antibiofilm Activity of Antibiotic-Loaded Bone Cements against Gram-Negative Bacteria
YAP promotes cell-autonomous immune responses to tackle intracellular Staphylococcus aureus in vitro
Improving the Diagnosis of Bacterial Infections: Evaluation of 16S rRNA Nanopore Metagenomics in Culture-Negative Samples
Transcriptome Architecture of Osteoblastic Cells Infected With Staphylococcus aureus Reveals Strong Inflammatory Responses and Signatures of Metabolic and Epigenetic Dysregulation
Methods to monitor bacterial growth and replicative rates at the single-cell level
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
Case Report: Arthroscopic “Debridement Antibiotics and Implant Retention” With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa Prosthetic Knee Infection
Prognostic factors of severe community-acquired staphylococcal pneumonia in France
Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection
Bone and Joint Infection Involving Corynebacterium spp.: From Clinical Features to Pathophysiological Pathways
Antibiotics in Bone Cements Used for Prosthesis Fixation: An Efficient Way to Prevent Staphylococcus aureus and Staphylococcus epidermidis Prosthetic Joint Infection
Staphylococcus aureus internalization impairs osteoblastic activity and early differentiation process
Implementation of a complex bone and joint infection phage therapy centre in France: lessons to be learned after 4 years' experience
Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection
<i>In vitro</i>antibiotic activity against intraosteoblastic<i>Staphylococcus aureus</i>: a narrative review of the literature
Reductive evolution of virulence repertoire to drive the divergence between community- and hospital-associated methicillin-resistant <i>Staphylococcus aureus</i> of the ST1 lineage
Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients With Relapsing S. aureus Prosthetic Knee Infection
The Potential Innovative Use of Bacteriophages Within the DAC® Hydrogel to Treat Patients With Knee Megaprosthesis Infection Requiring “Debridement Antibiotics and Implant Retention” and Soft Tissue Coverage as Salvage Therapy